ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2026
Modulating the Gut-Nerve Axis and Inflammation: A Narrative Review of Dietary Patterns in Diabetic Peripheral Neuropathy.
Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic peripheral neuropathy (DPN) is a prevalent and debilitating complication of diabetes, arising from a complex interplay of metabolic dysregulation, oxidative stress, and chronic inflammatory pathways. This narrative review synthesizes the core pathophysiology of DPN and critically evaluates the potential role of various dietary patterns in its management. Healthy patterns, such as the Mediterranean, DASH, and plant-based diets, may offer neuroprotective potential by improving systemic metabolic and inflammatory status. Conversely, pro-inflammatory diets remain associated with exacerbated nerve damage. Furthermore, emerging strategies like low-carbohydrate diets and intermittent fasting show promise in preclinical models via mechanisms such as metabolic reprogramming and autophagy, though direct clinical evidence in DPN populations remains emerging. A critical gap persists regarding the lack of large-scale, direct intervention studies in patients with established DPN. Future research must prioritize this population to build a robust evidence base for dietary strategies in secondary prevention and personalized therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.